# PeptideScanner evidence objects: LL-37

Every published version of the records placed with LL-37, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/ll-37.json. Selected public evidence only; not medical advice.

- Objects: 31
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct02225366-ll-37-v1"></a>

## ClinicalTrials.gov record NCT02225366

> PeptideScanner retained ClinicalTrials.gov record NCT02225366 at 2026-11-16T16:10:17.145Z. Its registry update date was 2021-12-09, and PeptideScanner's reviewed identity mapping was ll-37.

- Evidence object: `story:clinicaltrials-gov-nct02225366-ll-37:v1`
- Evidence domain: Clinical trials
- Date in source: 2021-12-09
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02225366-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#clinicaltrials-gov-nct02225366-ll-37-v1
- Content SHA-256: `80cd2eebe070dd873c22b126595af57073f20461b2852d0e6e25d9392e590f13`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02225366 ([`ctg-observation-nct02225366-2021-12-09-d146b413ecf5`](#source-ctg-observation-nct02225366-2021-12-09-d146b413ecf5))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02225366 at 2026-11-16T16:10:17.145Z. Its registry update date was 2021-12-09, and PeptideScanner's reviewed identity mapping was ll-37. ([`ctg-observation-nct02225366-2021-12-09-d146b413ecf5`](#source-ctg-observation-nct02225366-2021-12-09-d146b413ecf5))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02225366 at 2026-11-16T16:10:17.145Z. Its registry update date was 2021-12-09, and PeptideScanner's reviewed identity mapping was ll-37. ([`ctg-observation-nct02225366-2021-12-09-d146b413ecf5`](#source-ctg-observation-nct02225366-2021-12-09-d146b413ecf5))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02225366-2021-12-09-d146b413ecf5`](#source-ctg-observation-nct02225366-2021-12-09-d146b413ecf5))

### Sources

<a id="source-ctg-observation-nct02225366-2021-12-09-d146b413ecf5"></a>
- **ClinicalTrials.gov record NCT02225366 · retained source version 2021-12-09:d146b413ecf538257bf7086de94ac2024ae7cdada6f1e2c17c5051fba93f7d5c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02225366) (`ctg-observation-nct02225366-2021-12-09-d146b413ecf5`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02225366." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#clinicaltrials-gov-nct02225366-ll-37-v1 SHA-256: 80cd2eebe070dd873c22b126595af57073f20461b2852d0e6e25d9392e590f13.

---

<a id="pubmed-pmid-23931055-ll-37-v1"></a>

## Defensins and LL-37: a review of function in the gingival epithelium.

> PubMed lists PMID 23931055 in Periodontology 2000 as Journal Article, Research Support, N.I.H., Extramural, Review, with publication-date metadata of 2013-10 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23931055-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-05-15
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23931055-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-23931055-ll-37-v1
- Content SHA-256: `af994341daa9a24d59f70bf5847d6f76b2d95f7efbf8462c33b24d2c8288bb60`

### Claims and source pins

#### Headline

Defensins and LL-37: a review of function in the gingival epithelium. ([`pubmed-observation-pmid-23931055-2024-05-15-c05a5d1c43ea`](#source-pubmed-observation-pmid-23931055-2024-05-15-c05a5d1c43ea))

#### Summary

PubMed lists PMID 23931055 in Periodontology 2000 as Journal Article, Research Support, N.I.H., Extramural, Review, with publication-date metadata of 2013-10 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23931055-2024-05-15-c05a5d1c43ea`](#source-pubmed-observation-pmid-23931055-2024-05-15-c05a5d1c43ea))

#### Paragraph 1

PubMed lists PMID 23931055 in Periodontology 2000 as Journal Article, Research Support, N.I.H., Extramural, Review, with publication-date metadata of 2013-10 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23931055-2024-05-15-c05a5d1c43ea`](#source-pubmed-observation-pmid-23931055-2024-05-15-c05a5d1c43ea))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23931055-2024-05-15-c05a5d1c43ea`](#source-pubmed-observation-pmid-23931055-2024-05-15-c05a5d1c43ea))

### Sources

<a id="source-pubmed-observation-pmid-23931055-2024-05-15-c05a5d1c43ea"></a>
- **Defensins and LL-37: a review of function in the gingival epithelium. · retained source version 1:2024-05-15:current:c05a5d1c43eac40010f534749b0ae4d0e22d9096b220baaf49653808837fc077** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23931055/) (`pubmed-observation-pmid-23931055-2024-05-15-c05a5d1c43ea`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Defensins and LL-37: a review of function in the gingival epithelium." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-23931055-ll-37-v1 SHA-256: af994341daa9a24d59f70bf5847d6f76b2d95f7efbf8462c33b24d2c8288bb60.

---

<a id="pubmed-pmid-24463069-ll-37-v1"></a>

## High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.

> PubMed lists PMID 24463069 in Biochimica et biophysica acta as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2014-01-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24463069-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24463069-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-24463069-ll-37-v1
- Content SHA-256: `b366df48dd8c98d92529acbfb8d5498e85c3f8960070b1c10dee07050e4d7fe1`

### Claims and source pins

#### Headline

High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. ([`pubmed-observation-pmid-24463069-2022-12-07-7f7bccf7189f`](#source-pubmed-observation-pmid-24463069-2022-12-07-7f7bccf7189f))

#### Summary

PubMed lists PMID 24463069 in Biochimica et biophysica acta as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2014-01-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24463069-2022-12-07-7f7bccf7189f`](#source-pubmed-observation-pmid-24463069-2022-12-07-7f7bccf7189f))

#### Paragraph 1

PubMed lists PMID 24463069 in Biochimica et biophysica acta as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2014-01-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24463069-2022-12-07-7f7bccf7189f`](#source-pubmed-observation-pmid-24463069-2022-12-07-7f7bccf7189f))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24463069-2022-12-07-7f7bccf7189f`](#source-pubmed-observation-pmid-24463069-2022-12-07-7f7bccf7189f))

### Sources

<a id="source-pubmed-observation-pmid-24463069-2022-12-07-7f7bccf7189f"></a>
- **High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. · retained source version 1:2022-12-07:current:7f7bccf7189f059712f40a37bcf47b2a1c04b46a8fb3a84d6659808f5a54ef55** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24463069/) (`pubmed-observation-pmid-24463069-2022-12-07-7f7bccf7189f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-24463069-ll-37-v1 SHA-256: b366df48dd8c98d92529acbfb8d5498e85c3f8960070b1c10dee07050e4d7fe1.

---

<a id="pubmed-pmid-24738326-ll-37-v1"></a>

## \[A review: the role of antimicrobial peptide LL-37 in chronic sinusitis\].

> PubMed lists PMID 24738326 in Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery as Journal Article, Review, with publication-date metadata of 2014-01 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24738326-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24738326-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-24738326-ll-37-v1
- Content SHA-256: `0d1060294f6c573d2a6bd1e5723c337821fe31bb9396f1ecdfbb4cf873a059cd`

### Claims and source pins

#### Headline

\[A review: the role of antimicrobial peptide LL-37 in chronic sinusitis\]. ([`pubmed-observation-pmid-24738326-2022-12-07-c56a49bae02d`](#source-pubmed-observation-pmid-24738326-2022-12-07-c56a49bae02d))

#### Summary

PubMed lists PMID 24738326 in Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery as Journal Article, Review, with publication-date metadata of 2014-01 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24738326-2022-12-07-c56a49bae02d`](#source-pubmed-observation-pmid-24738326-2022-12-07-c56a49bae02d))

#### Paragraph 1

PubMed lists PMID 24738326 in Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery as Journal Article, Review, with publication-date metadata of 2014-01 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24738326-2022-12-07-c56a49bae02d`](#source-pubmed-observation-pmid-24738326-2022-12-07-c56a49bae02d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24738326-2022-12-07-c56a49bae02d`](#source-pubmed-observation-pmid-24738326-2022-12-07-c56a49bae02d))

### Sources

<a id="source-pubmed-observation-pmid-24738326-2022-12-07-c56a49bae02d"></a>
- **\[A review: the role of antimicrobial peptide LL-37 in chronic sinusitis\]. · retained source version 1:2022-12-07:current:c56a49bae02d4e633027b5649e45681c64e1a14a107d9d6986d79eb8b0097c2b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24738326/) (`pubmed-observation-pmid-24738326-2022-12-07-c56a49bae02d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[A review: the role of antimicrobial peptide LL-37 in chronic sinusitis\]." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-24738326-ll-37-v1 SHA-256: 0d1060294f6c573d2a6bd1e5723c337821fe31bb9396f1ecdfbb4cf873a059cd.

---

<a id="pubmed-pmid-25101632-ll-37-v1"></a>

## Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice.

> PubMed lists PMID 25101632 in Protein and peptide letters as Journal Article, Review, with publication-date metadata of 2014 (year precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-25101632-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25101632-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-25101632-ll-37-v1
- Content SHA-256: `a93761547f513675210464076eff78c3430007f6fb03cc4fdffcd85ebe578d72`

### Claims and source pins

#### Headline

Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice. ([`pubmed-observation-pmid-25101632-2022-12-07-32e2c715cd5b`](#source-pubmed-observation-pmid-25101632-2022-12-07-32e2c715cd5b))

#### Summary

PubMed lists PMID 25101632 in Protein and peptide letters as Journal Article, Review, with publication-date metadata of 2014 (year precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25101632-2022-12-07-32e2c715cd5b`](#source-pubmed-observation-pmid-25101632-2022-12-07-32e2c715cd5b))

#### Paragraph 1

PubMed lists PMID 25101632 in Protein and peptide letters as Journal Article, Review, with publication-date metadata of 2014 (year precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25101632-2022-12-07-32e2c715cd5b`](#source-pubmed-observation-pmid-25101632-2022-12-07-32e2c715cd5b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25101632-2022-12-07-32e2c715cd5b`](#source-pubmed-observation-pmid-25101632-2022-12-07-32e2c715cd5b))

### Sources

<a id="source-pubmed-observation-pmid-25101632-2022-12-07-32e2c715cd5b"></a>
- **Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice. · retained source version 1:2022-12-07:current:32e2c715cd5b8ad6738574b6efda6ae9ce1b3fb9500699fae8058736aeed4f26** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25101632/) (`pubmed-observation-pmid-25101632-2022-12-07-32e2c715cd5b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-25101632-ll-37-v1 SHA-256: a93761547f513675210464076eff78c3430007f6fb03cc4fdffcd85ebe578d72.

---

<a id="pubmed-pmid-26395996-ll-37-v1"></a>

## The Role of Cathelicidin LL-37 in Cancer Development.

> PubMed lists PMID 26395996 in Archivum immunologiae et therapiae experimentalis as Journal Article, Review, with publication-date metadata of 2015-09-22 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-26395996-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-26395996-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-26395996-ll-37-v1
- Content SHA-256: `d0c2ec029438c3ae5f0a0a6f6afdde349f649fcbc2e00b01156255310ba4653e`

### Claims and source pins

#### Headline

The Role of Cathelicidin LL-37 in Cancer Development. ([`pubmed-observation-pmid-26395996-2022-12-07-fcf3d63d0d66`](#source-pubmed-observation-pmid-26395996-2022-12-07-fcf3d63d0d66))

#### Summary

PubMed lists PMID 26395996 in Archivum immunologiae et therapiae experimentalis as Journal Article, Review, with publication-date metadata of 2015-09-22 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26395996-2022-12-07-fcf3d63d0d66`](#source-pubmed-observation-pmid-26395996-2022-12-07-fcf3d63d0d66))

#### Paragraph 1

PubMed lists PMID 26395996 in Archivum immunologiae et therapiae experimentalis as Journal Article, Review, with publication-date metadata of 2015-09-22 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26395996-2022-12-07-fcf3d63d0d66`](#source-pubmed-observation-pmid-26395996-2022-12-07-fcf3d63d0d66))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-26395996-2022-12-07-fcf3d63d0d66`](#source-pubmed-observation-pmid-26395996-2022-12-07-fcf3d63d0d66))

### Sources

<a id="source-pubmed-observation-pmid-26395996-2022-12-07-fcf3d63d0d66"></a>
- **The Role of Cathelicidin LL-37 in Cancer Development. · retained source version 1:2022-12-07:current:fcf3d63d0d66451a2f5d5683e8e08cf1a553bf981f12cdbb66451d938ae38a3f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/26395996/) (`pubmed-observation-pmid-26395996-2022-12-07-fcf3d63d0d66`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "The Role of Cathelicidin LL-37 in Cancer Development." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-26395996-ll-37-v1 SHA-256: d0c2ec029438c3ae5f0a0a6f6afdde349f649fcbc2e00b01156255310ba4653e.

---

<a id="pubmed-pmid-26434733-ll-37-v1"></a>

## Unique features of human cathelicidin LL-37.

> PubMed lists PMID 26434733 in BioFactors (Oxford, England) as Journal Article, Review, with publication-date metadata of 2015-10-05 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-26434733-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-26434733-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-26434733-ll-37-v1
- Content SHA-256: `ad220e1f4c77fe30c1f8f9b80bc625974af39bbb8c74ca95e7724f8e93e0b227`

### Claims and source pins

#### Headline

Unique features of human cathelicidin LL-37. ([`pubmed-observation-pmid-26434733-2022-12-07-09ff42a4ce25`](#source-pubmed-observation-pmid-26434733-2022-12-07-09ff42a4ce25))

#### Summary

PubMed lists PMID 26434733 in BioFactors (Oxford, England) as Journal Article, Review, with publication-date metadata of 2015-10-05 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26434733-2022-12-07-09ff42a4ce25`](#source-pubmed-observation-pmid-26434733-2022-12-07-09ff42a4ce25))

#### Paragraph 1

PubMed lists PMID 26434733 in BioFactors (Oxford, England) as Journal Article, Review, with publication-date metadata of 2015-10-05 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26434733-2022-12-07-09ff42a4ce25`](#source-pubmed-observation-pmid-26434733-2022-12-07-09ff42a4ce25))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-26434733-2022-12-07-09ff42a4ce25`](#source-pubmed-observation-pmid-26434733-2022-12-07-09ff42a4ce25))

### Sources

<a id="source-pubmed-observation-pmid-26434733-2022-12-07-09ff42a4ce25"></a>
- **Unique features of human cathelicidin LL-37. · retained source version 1:2022-12-07:current:09ff42a4ce253001d7e4392dc5ebe91acabd67870c2a8fb648185051b13ad4ae** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/26434733/) (`pubmed-observation-pmid-26434733-2022-12-07-09ff42a4ce25`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Unique features of human cathelicidin LL-37." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-26434733-ll-37-v1 SHA-256: ad220e1f4c77fe30c1f8f9b80bc625974af39bbb8c74ca95e7724f8e93e0b227.

---

<a id="pubmed-pmid-27117377-ll-37-v1"></a>

## LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity.

> PubMed lists PMID 27117377 in Pharmacological reports : PR as Journal Article, Review, with publication-date metadata of 2016-04-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-27117377-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27117377-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-27117377-ll-37-v1
- Content SHA-256: `7e9478f4903688c17cda610987f55937bdb81c8b9c2c4614759aef1021ffb000`

### Claims and source pins

#### Headline

LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity. ([`pubmed-observation-pmid-27117377-2022-12-07-e3fe5d120c91`](#source-pubmed-observation-pmid-27117377-2022-12-07-e3fe5d120c91))

#### Summary

PubMed lists PMID 27117377 in Pharmacological reports : PR as Journal Article, Review, with publication-date metadata of 2016-04-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27117377-2022-12-07-e3fe5d120c91`](#source-pubmed-observation-pmid-27117377-2022-12-07-e3fe5d120c91))

#### Paragraph 1

PubMed lists PMID 27117377 in Pharmacological reports : PR as Journal Article, Review, with publication-date metadata of 2016-04-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27117377-2022-12-07-e3fe5d120c91`](#source-pubmed-observation-pmid-27117377-2022-12-07-e3fe5d120c91))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27117377-2022-12-07-e3fe5d120c91`](#source-pubmed-observation-pmid-27117377-2022-12-07-e3fe5d120c91))

### Sources

<a id="source-pubmed-observation-pmid-27117377-2022-12-07-e3fe5d120c91"></a>
- **LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity. · retained source version 1:2022-12-07:current:e3fe5d120c911453c399ed114794389860b8b25eb688e20b854a21a3f2cdcad3** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27117377/) (`pubmed-observation-pmid-27117377-2022-12-07-e3fe5d120c91`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-27117377-ll-37-v1 SHA-256: 7e9478f4903688c17cda610987f55937bdb81c8b9c2c4614759aef1021ffb000.

---

<a id="pubmed-pmid-27135484-ll-37-v1"></a>

## The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.

> PubMed lists PMID 27135484 in Inflammatory bowel diseases as Journal Article, Review, with publication-date metadata of 2016-08 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-27135484-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27135484-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-27135484-ll-37-v1
- Content SHA-256: `aa03eb133189b40e281be755640e6bb9a522602615c8839cda1a3cf8244484d5`

### Claims and source pins

#### Headline

The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease. ([`pubmed-observation-pmid-27135484-2022-12-07-1ba9bb0eeec7`](#source-pubmed-observation-pmid-27135484-2022-12-07-1ba9bb0eeec7))

#### Summary

PubMed lists PMID 27135484 in Inflammatory bowel diseases as Journal Article, Review, with publication-date metadata of 2016-08 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27135484-2022-12-07-1ba9bb0eeec7`](#source-pubmed-observation-pmid-27135484-2022-12-07-1ba9bb0eeec7))

#### Paragraph 1

PubMed lists PMID 27135484 in Inflammatory bowel diseases as Journal Article, Review, with publication-date metadata of 2016-08 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27135484-2022-12-07-1ba9bb0eeec7`](#source-pubmed-observation-pmid-27135484-2022-12-07-1ba9bb0eeec7))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27135484-2022-12-07-1ba9bb0eeec7`](#source-pubmed-observation-pmid-27135484-2022-12-07-1ba9bb0eeec7))

### Sources

<a id="source-pubmed-observation-pmid-27135484-2022-12-07-1ba9bb0eeec7"></a>
- **The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease. · retained source version 1:2022-12-07:current:1ba9bb0eeec7157997c852eb0823891a4e77182050f9651c9337002004855052** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27135484/) (`pubmed-observation-pmid-27135484-2022-12-07-1ba9bb0eeec7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-27135484-ll-37-v1 SHA-256: aa03eb133189b40e281be755640e6bb9a522602615c8839cda1a3cf8244484d5.

---

<a id="pubmed-pmid-28218580-ll-37-v1"></a>

## Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases.

> PubMed lists PMID 28218580 in Clinical and investigative medicine. Medecine clinique et experimentale as Clinical Trial, Journal Article, with publication-date metadata of 2017-02-19 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-28218580-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-28218580-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-28218580-ll-37-v1
- Content SHA-256: `3653f01870e8deee3d9d7495a95355b2a842226cb747da4de4068a1893ae873c`

### Claims and source pins

#### Headline

Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases. ([`pubmed-observation-pmid-28218580-2022-12-07-cdfee98a1f3b`](#source-pubmed-observation-pmid-28218580-2022-12-07-cdfee98a1f3b))

#### Summary

PubMed lists PMID 28218580 in Clinical and investigative medicine. Medecine clinique et experimentale as Clinical Trial, Journal Article, with publication-date metadata of 2017-02-19 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28218580-2022-12-07-cdfee98a1f3b`](#source-pubmed-observation-pmid-28218580-2022-12-07-cdfee98a1f3b))

#### Paragraph 1

PubMed lists PMID 28218580 in Clinical and investigative medicine. Medecine clinique et experimentale as Clinical Trial, Journal Article, with publication-date metadata of 2017-02-19 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28218580-2022-12-07-cdfee98a1f3b`](#source-pubmed-observation-pmid-28218580-2022-12-07-cdfee98a1f3b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-28218580-2022-12-07-cdfee98a1f3b`](#source-pubmed-observation-pmid-28218580-2022-12-07-cdfee98a1f3b))

### Sources

<a id="source-pubmed-observation-pmid-28218580-2022-12-07-cdfee98a1f3b"></a>
- **Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases. · retained source version 1:2022-12-07:current:cdfee98a1f3bb7eff3f3113e65c1f9bd0605ac19bed88f3122dc9574753d2307** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/28218580/) (`pubmed-observation-pmid-28218580-2022-12-07-cdfee98a1f3b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-28218580-ll-37-v1 SHA-256: 3653f01870e8deee3d9d7495a95355b2a842226cb747da4de4068a1893ae873c.

---

<a id="pubmed-pmid-28956425-ll-37-v1"></a>

## Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases.

> PubMed lists PMID 28956425 in Journal of biological regulators and homeostatic agents as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2017 Jul-Sep (source-text precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-28956425-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-28956425-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-28956425-ll-37-v1
- Content SHA-256: `5cd74328687f48d90554665073c9ee62d6cfdb6c86ca0bf683e2938cce5e0f6f`

### Claims and source pins

#### Headline

Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases. ([`pubmed-observation-pmid-28956425-2022-12-07-5acf75688832`](#source-pubmed-observation-pmid-28956425-2022-12-07-5acf75688832))

#### Summary

PubMed lists PMID 28956425 in Journal of biological regulators and homeostatic agents as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2017 Jul-Sep (source-text precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28956425-2022-12-07-5acf75688832`](#source-pubmed-observation-pmid-28956425-2022-12-07-5acf75688832))

#### Paragraph 1

PubMed lists PMID 28956425 in Journal of biological regulators and homeostatic agents as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2017 Jul-Sep (source-text precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28956425-2022-12-07-5acf75688832`](#source-pubmed-observation-pmid-28956425-2022-12-07-5acf75688832))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-28956425-2022-12-07-5acf75688832`](#source-pubmed-observation-pmid-28956425-2022-12-07-5acf75688832))

### Sources

<a id="source-pubmed-observation-pmid-28956425-2022-12-07-5acf75688832"></a>
- **Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases. · retained source version 1:2022-12-07:current:5acf7568883220da5abfee1da0efafb612fb730361911c7b5165e373db1c9b7d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/28956425/) (`pubmed-observation-pmid-28956425-2022-12-07-5acf75688832`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-28956425-ll-37-v1 SHA-256: 5cd74328687f48d90554665073c9ee62d6cfdb6c86ca0bf683e2938cce5e0f6f.

---

<a id="pubmed-pmid-29843147-ll-37-v1"></a>

## Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer.

> PubMed lists PMID 29843147 in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology as Journal Article, Review, with publication-date metadata of 2018-05-25 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-29843147-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29843147-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-29843147-ll-37-v1
- Content SHA-256: `913ade6793d09d02f842fed7639eb3b3c746a79227984d871c2e9f702755275b`

### Claims and source pins

#### Headline

Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer. ([`pubmed-observation-pmid-29843147-2022-12-07-01814f5a48c0`](#source-pubmed-observation-pmid-29843147-2022-12-07-01814f5a48c0))

#### Summary

PubMed lists PMID 29843147 in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology as Journal Article, Review, with publication-date metadata of 2018-05-25 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29843147-2022-12-07-01814f5a48c0`](#source-pubmed-observation-pmid-29843147-2022-12-07-01814f5a48c0))

#### Paragraph 1

PubMed lists PMID 29843147 in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology as Journal Article, Review, with publication-date metadata of 2018-05-25 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29843147-2022-12-07-01814f5a48c0`](#source-pubmed-observation-pmid-29843147-2022-12-07-01814f5a48c0))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29843147-2022-12-07-01814f5a48c0`](#source-pubmed-observation-pmid-29843147-2022-12-07-01814f5a48c0))

### Sources

<a id="source-pubmed-observation-pmid-29843147-2022-12-07-01814f5a48c0"></a>
- **Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer. · retained source version 1:2022-12-07:current:01814f5a48c0c3afe3358d22d648566044f975ccd1a71d3ce42736bee29bf954** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29843147/) (`pubmed-observation-pmid-29843147-2022-12-07-01814f5a48c0`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-29843147-ll-37-v1 SHA-256: 913ade6793d09d02f842fed7639eb3b3c746a79227984d871c2e9f702755275b.

---

<a id="pubmed-pmid-30980360-ll-37-v1"></a>

## Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.

> PubMed lists PMID 30980360 in Advances in experimental medicine and biology as Journal Article, Review, with publication-date metadata of 2019 (year precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30980360-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30980360-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-30980360-ll-37-v1
- Content SHA-256: `20de9e2a04d2333dd972c1725d730fa235da2f359ef3120999c46328175b675a`

### Claims and source pins

#### Headline

Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37. ([`pubmed-observation-pmid-30980360-2022-12-07-ed19bf12d468`](#source-pubmed-observation-pmid-30980360-2022-12-07-ed19bf12d468))

#### Summary

PubMed lists PMID 30980360 in Advances in experimental medicine and biology as Journal Article, Review, with publication-date metadata of 2019 (year precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30980360-2022-12-07-ed19bf12d468`](#source-pubmed-observation-pmid-30980360-2022-12-07-ed19bf12d468))

#### Paragraph 1

PubMed lists PMID 30980360 in Advances in experimental medicine and biology as Journal Article, Review, with publication-date metadata of 2019 (year precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30980360-2022-12-07-ed19bf12d468`](#source-pubmed-observation-pmid-30980360-2022-12-07-ed19bf12d468))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30980360-2022-12-07-ed19bf12d468`](#source-pubmed-observation-pmid-30980360-2022-12-07-ed19bf12d468))

### Sources

<a id="source-pubmed-observation-pmid-30980360-2022-12-07-ed19bf12d468"></a>
- **Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37. · retained source version 1:2022-12-07:current:ed19bf12d4686186594d94d9c5bb9a945758f0a48bd3149b0a4984cc4dec116b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30980360/) (`pubmed-observation-pmid-30980360-2022-12-07-ed19bf12d468`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-30980360-ll-37-v1 SHA-256: 20de9e2a04d2333dd972c1725d730fa235da2f359ef3120999c46328175b675a.

---

<a id="pubmed-pmid-31687504-ll-37-v1"></a>

## Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells.

> PubMed lists PMID 31687504 in Heliyon as Journal Article, Review, with publication-date metadata of 2019-10-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-31687504-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-07-21
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31687504-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-31687504-ll-37-v1
- Content SHA-256: `3b24c2daf8c70a98b54262208720375f59a279dde1f1fe8e0421c3191379dcec`

### Claims and source pins

#### Headline

Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells. ([`pubmed-observation-pmid-31687504-2024-07-21-06a7c6bc7fab`](#source-pubmed-observation-pmid-31687504-2024-07-21-06a7c6bc7fab))

#### Summary

PubMed lists PMID 31687504 in Heliyon as Journal Article, Review, with publication-date metadata of 2019-10-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31687504-2024-07-21-06a7c6bc7fab`](#source-pubmed-observation-pmid-31687504-2024-07-21-06a7c6bc7fab))

#### Paragraph 1

PubMed lists PMID 31687504 in Heliyon as Journal Article, Review, with publication-date metadata of 2019-10-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31687504-2024-07-21-06a7c6bc7fab`](#source-pubmed-observation-pmid-31687504-2024-07-21-06a7c6bc7fab))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31687504-2024-07-21-06a7c6bc7fab`](#source-pubmed-observation-pmid-31687504-2024-07-21-06a7c6bc7fab))

### Sources

<a id="source-pubmed-observation-pmid-31687504-2024-07-21-06a7c6bc7fab"></a>
- **Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells. · retained source version 1:2024-07-21:current:06a7c6bc7fab6882c181e081b6a363922be9c24dc6d4b81da237efab3a52d345** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31687504/) (`pubmed-observation-pmid-31687504-2024-07-21-06a7c6bc7fab`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-31687504-ll-37-v1 SHA-256: 3b24c2daf8c70a98b54262208720375f59a279dde1f1fe8e0421c3191379dcec.

---

<a id="pubmed-pmid-32743514-ll-37-v1"></a>

## Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus.

> PubMed lists PMID 32743514 in Journal of translational autoimmunity as Journal Article, Review, with publication-date metadata of 2019-12-17 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-32743514-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-09-28
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-32743514-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-32743514-ll-37-v1
- Content SHA-256: `990f283d1cec1b17abbc4034b191e4a6aa7f7a46701a00d12b99f5886300d988`

### Claims and source pins

#### Headline

Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus. ([`pubmed-observation-pmid-32743514-2020-09-28-72131aba56ed`](#source-pubmed-observation-pmid-32743514-2020-09-28-72131aba56ed))

#### Summary

PubMed lists PMID 32743514 in Journal of translational autoimmunity as Journal Article, Review, with publication-date metadata of 2019-12-17 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32743514-2020-09-28-72131aba56ed`](#source-pubmed-observation-pmid-32743514-2020-09-28-72131aba56ed))

#### Paragraph 1

PubMed lists PMID 32743514 in Journal of translational autoimmunity as Journal Article, Review, with publication-date metadata of 2019-12-17 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32743514-2020-09-28-72131aba56ed`](#source-pubmed-observation-pmid-32743514-2020-09-28-72131aba56ed))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-32743514-2020-09-28-72131aba56ed`](#source-pubmed-observation-pmid-32743514-2020-09-28-72131aba56ed))

### Sources

<a id="source-pubmed-observation-pmid-32743514-2020-09-28-72131aba56ed"></a>
- **Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus. · retained source version 1:2020-09-28:current:72131aba56ed62a23633a44bc35c8136b54ccc6a8062dfa17ffeec57f9ddccaf** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/32743514/) (`pubmed-observation-pmid-32743514-2020-09-28-72131aba56ed`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-32743514-ll-37-v1 SHA-256: 990f283d1cec1b17abbc4034b191e4a6aa7f7a46701a00d12b99f5886300d988.

---

<a id="pubmed-pmid-32927756-ll-37-v1"></a>

## Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections.

> PubMed lists PMID 32927756 in Vaccines as Journal Article, Review, with publication-date metadata of 2020-09-10 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-32927756-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-11-12
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-32927756-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-32927756-ll-37-v1
- Content SHA-256: `f4013e8857aeb16c16f00ff23897ea66b184d89d0c4106f36466646ccb44cea6`

### Claims and source pins

#### Headline

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections. ([`pubmed-observation-pmid-32927756-2023-11-12-ad0c9d1b303f`](#source-pubmed-observation-pmid-32927756-2023-11-12-ad0c9d1b303f))

#### Summary

PubMed lists PMID 32927756 in Vaccines as Journal Article, Review, with publication-date metadata of 2020-09-10 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32927756-2023-11-12-ad0c9d1b303f`](#source-pubmed-observation-pmid-32927756-2023-11-12-ad0c9d1b303f))

#### Paragraph 1

PubMed lists PMID 32927756 in Vaccines as Journal Article, Review, with publication-date metadata of 2020-09-10 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32927756-2023-11-12-ad0c9d1b303f`](#source-pubmed-observation-pmid-32927756-2023-11-12-ad0c9d1b303f))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-32927756-2023-11-12-ad0c9d1b303f`](#source-pubmed-observation-pmid-32927756-2023-11-12-ad0c9d1b303f))

### Sources

<a id="source-pubmed-observation-pmid-32927756-2023-11-12-ad0c9d1b303f"></a>
- **Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections. · retained source version 1:2023-11-12:current:ad0c9d1b303f5ecb21580870195633a344d3b35ddc4728d39547174826b8d741** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/32927756/) (`pubmed-observation-pmid-32927756-2023-11-12-ad0c9d1b303f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-32927756-ll-37-v1 SHA-256: f4013e8857aeb16c16f00ff23897ea66b184d89d0c4106f36466646ccb44cea6.

---

<a id="pubmed-pmid-34068993-ll-37-v1"></a>

## Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures.

> PubMed lists PMID 34068993 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2021-05-14 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34068993-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-12-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34068993-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-34068993-ll-37-v1
- Content SHA-256: `ab63c0dab57c4de904d80261773f6f300d360f4500236125cb3b06f09440dc4e`

### Claims and source pins

#### Headline

Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures. ([`pubmed-observation-pmid-34068993-2022-12-07-9c1a28a71ec6`](#source-pubmed-observation-pmid-34068993-2022-12-07-9c1a28a71ec6))

#### Summary

PubMed lists PMID 34068993 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2021-05-14 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34068993-2022-12-07-9c1a28a71ec6`](#source-pubmed-observation-pmid-34068993-2022-12-07-9c1a28a71ec6))

#### Paragraph 1

PubMed lists PMID 34068993 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2021-05-14 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34068993-2022-12-07-9c1a28a71ec6`](#source-pubmed-observation-pmid-34068993-2022-12-07-9c1a28a71ec6))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34068993-2022-12-07-9c1a28a71ec6`](#source-pubmed-observation-pmid-34068993-2022-12-07-9c1a28a71ec6))

### Sources

<a id="source-pubmed-observation-pmid-34068993-2022-12-07-9c1a28a71ec6"></a>
- **Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures. · retained source version 1:2022-12-07:current:9c1a28a71ec62cfe2c3ecd4871734a3465f0ba2ced0accae7fba3ad977dd1da1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34068993/) (`pubmed-observation-pmid-34068993-2022-12-07-9c1a28a71ec6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-34068993-ll-37-v1 SHA-256: ab63c0dab57c4de904d80261773f6f300d360f4500236125cb3b06f09440dc4e.

---

<a id="pubmed-pmid-36081952-ll-37-v1"></a>

## Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy.

> PubMed lists PMID 36081952 in Frontiers in pharmacology as Journal Article, Review, with publication-date metadata of 2022-08-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36081952-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-09-12
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36081952-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-36081952-ll-37-v1
- Content SHA-256: `592714b4f16de96df0d506c28400d7ef7446ff66552ec805012ab2b2d68063de`

### Claims and source pins

#### Headline

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy. ([`pubmed-observation-pmid-36081952-2022-09-12-6ae696854ed6`](#source-pubmed-observation-pmid-36081952-2022-09-12-6ae696854ed6))

#### Summary

PubMed lists PMID 36081952 in Frontiers in pharmacology as Journal Article, Review, with publication-date metadata of 2022-08-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36081952-2022-09-12-6ae696854ed6`](#source-pubmed-observation-pmid-36081952-2022-09-12-6ae696854ed6))

#### Paragraph 1

PubMed lists PMID 36081952 in Frontiers in pharmacology as Journal Article, Review, with publication-date metadata of 2022-08-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36081952-2022-09-12-6ae696854ed6`](#source-pubmed-observation-pmid-36081952-2022-09-12-6ae696854ed6))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36081952-2022-09-12-6ae696854ed6`](#source-pubmed-observation-pmid-36081952-2022-09-12-6ae696854ed6))

### Sources

<a id="source-pubmed-observation-pmid-36081952-2022-09-12-6ae696854ed6"></a>
- **Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy. · retained source version 1:2022-09-12:current:6ae696854ed6a9231294c347627a3b419dec628429353c355ced9a0f4b3ffbdf** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36081952/) (`pubmed-observation-pmid-36081952-2022-09-12-6ae696854ed6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-36081952-ll-37-v1 SHA-256: 592714b4f16de96df0d506c28400d7ef7446ff66552ec805012ab2b2d68063de.

---

<a id="pubmed-pmid-36781570-ll-37-v1"></a>

## Antibiofilm properties of cathelicidin LL-37: an in-depth review.

> PubMed lists PMID 36781570 in World journal of microbiology & biotechnology as Review, Journal Article, with publication-date metadata of 2023-02-14 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36781570-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-30
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36781570-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-36781570-ll-37-v1
- Content SHA-256: `f748edbbc8d99eb8e2bf7da8ef05c380ef5ecf3c0dd0791cbf62273c1d072ccf`

### Claims and source pins

#### Headline

Antibiofilm properties of cathelicidin LL-37: an in-depth review. ([`pubmed-observation-pmid-36781570-2026-10-30-d4fe8cd8a98b`](#source-pubmed-observation-pmid-36781570-2026-10-30-d4fe8cd8a98b))

#### Summary

PubMed lists PMID 36781570 in World journal of microbiology & biotechnology as Review, Journal Article, with publication-date metadata of 2023-02-14 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36781570-2026-10-30-d4fe8cd8a98b`](#source-pubmed-observation-pmid-36781570-2026-10-30-d4fe8cd8a98b))

#### Paragraph 1

PubMed lists PMID 36781570 in World journal of microbiology & biotechnology as Review, Journal Article, with publication-date metadata of 2023-02-14 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36781570-2026-10-30-d4fe8cd8a98b`](#source-pubmed-observation-pmid-36781570-2026-10-30-d4fe8cd8a98b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36781570-2026-10-30-d4fe8cd8a98b`](#source-pubmed-observation-pmid-36781570-2026-10-30-d4fe8cd8a98b))

### Sources

<a id="source-pubmed-observation-pmid-36781570-2026-10-30-d4fe8cd8a98b"></a>
- **Antibiofilm properties of cathelicidin LL-37: an in-depth review. · retained source version 1:2026-10-30:current:d4fe8cd8a98b91e036841b62445b286d7aa3f85832c477865a6b668e1194235b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36781570/) (`pubmed-observation-pmid-36781570-2026-10-30-d4fe8cd8a98b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Antibiofilm properties of cathelicidin LL-37: an in-depth review." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-36781570-ll-37-v1 SHA-256: f748edbbc8d99eb8e2bf7da8ef05c380ef5ecf3c0dd0791cbf62273c1d072ccf.

---

<a id="pubmed-pmid-37919905-ll-37-v1"></a>

## Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids.

> PubMed lists PMID 37919905 in Biophysical journal as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-11-02 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-37919905-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-03-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-37919905-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-37919905-ll-37-v1
- Content SHA-256: `da8e19c44bfd5c81da4c08a20d640cea0d9fe2f2548a2450bbb65636032b842a`

### Claims and source pins

#### Headline

Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids. ([`pubmed-observation-pmid-37919905-2026-03-07-b37e392ae70b`](#source-pubmed-observation-pmid-37919905-2026-03-07-b37e392ae70b))

#### Summary

PubMed lists PMID 37919905 in Biophysical journal as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-11-02 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-37919905-2026-03-07-b37e392ae70b`](#source-pubmed-observation-pmid-37919905-2026-03-07-b37e392ae70b))

#### Paragraph 1

PubMed lists PMID 37919905 in Biophysical journal as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-11-02 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-37919905-2026-03-07-b37e392ae70b`](#source-pubmed-observation-pmid-37919905-2026-03-07-b37e392ae70b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-37919905-2026-03-07-b37e392ae70b`](#source-pubmed-observation-pmid-37919905-2026-03-07-b37e392ae70b))

### Sources

<a id="source-pubmed-observation-pmid-37919905-2026-03-07-b37e392ae70b"></a>
- **Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids. · retained source version 1:2026-03-07:current:b37e392ae70b49356012914ce127bd0fd46a6f392deab32c4eba15f0884264c8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/37919905/) (`pubmed-observation-pmid-37919905-2026-03-07-b37e392ae70b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-37919905-ll-37-v1 SHA-256: da8e19c44bfd5c81da4c08a20d640cea0d9fe2f2548a2450bbb65636032b842a.

---

<a id="pubmed-pmid-38057654-ll-37-v1"></a>

## Antifungal properties of cathelicidin LL-37: current knowledge and future research directions.

> PubMed lists PMID 38057654 in World journal of microbiology & biotechnology as Journal Article, Review, with publication-date metadata of 2023-12-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38057654-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-31
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38057654-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-38057654-ll-37-v1
- Content SHA-256: `1678690ccdfdd21b5efe3b8b379f4dda5d145da4f8281c81cf6cb4a18b9e1eda`

### Claims and source pins

#### Headline

Antifungal properties of cathelicidin LL-37: current knowledge and future research directions. ([`pubmed-observation-pmid-38057654-2026-10-31-db82591e4f14`](#source-pubmed-observation-pmid-38057654-2026-10-31-db82591e4f14))

#### Summary

PubMed lists PMID 38057654 in World journal of microbiology & biotechnology as Journal Article, Review, with publication-date metadata of 2023-12-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38057654-2026-10-31-db82591e4f14`](#source-pubmed-observation-pmid-38057654-2026-10-31-db82591e4f14))

#### Paragraph 1

PubMed lists PMID 38057654 in World journal of microbiology & biotechnology as Journal Article, Review, with publication-date metadata of 2023-12-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38057654-2026-10-31-db82591e4f14`](#source-pubmed-observation-pmid-38057654-2026-10-31-db82591e4f14))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38057654-2026-10-31-db82591e4f14`](#source-pubmed-observation-pmid-38057654-2026-10-31-db82591e4f14))

### Sources

<a id="source-pubmed-observation-pmid-38057654-2026-10-31-db82591e4f14"></a>
- **Antifungal properties of cathelicidin LL-37: current knowledge and future research directions. · retained source version 1:2026-10-31:current:db82591e4f148ba537b3daa5cece1fb1d1f0310c4190d0cac05c49c8a32dc872** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38057654/) (`pubmed-observation-pmid-38057654-2026-10-31-db82591e4f14`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Antifungal properties of cathelicidin LL-37: current knowledge and future research directions." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-38057654-ll-37-v1 SHA-256: 1678690ccdfdd21b5efe3b8b379f4dda5d145da4f8281c81cf6cb4a18b9e1eda.

---

<a id="pubmed-pmid-38540740-ll-37-v1"></a>

## LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases.

> PubMed lists PMID 38540740 in Biomolecules as Journal Article, Review, Research Support, N.I.H., Extramural, with publication-date metadata of 2024-03-08 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38540740-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-16
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38540740-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-38540740-ll-37-v1
- Content SHA-256: `294da1e198322cf9ac6f5d15542ecfe5273733879b1f77c0fd33b26f0e4fc5c0`

### Claims and source pins

#### Headline

LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases. ([`pubmed-observation-pmid-38540740-2026-04-16-641e5140165d`](#source-pubmed-observation-pmid-38540740-2026-04-16-641e5140165d))

#### Summary

PubMed lists PMID 38540740 in Biomolecules as Journal Article, Review, Research Support, N.I.H., Extramural, with publication-date metadata of 2024-03-08 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38540740-2026-04-16-641e5140165d`](#source-pubmed-observation-pmid-38540740-2026-04-16-641e5140165d))

#### Paragraph 1

PubMed lists PMID 38540740 in Biomolecules as Journal Article, Review, Research Support, N.I.H., Extramural, with publication-date metadata of 2024-03-08 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38540740-2026-04-16-641e5140165d`](#source-pubmed-observation-pmid-38540740-2026-04-16-641e5140165d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38540740-2026-04-16-641e5140165d`](#source-pubmed-observation-pmid-38540740-2026-04-16-641e5140165d))

### Sources

<a id="source-pubmed-observation-pmid-38540740-2026-04-16-641e5140165d"></a>
- **LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases. · retained source version 1:2026-04-16:current:641e5140165dec1d7cae3ce25b4c090f2cdfaabe718b22c6406fe9f3e21b085d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38540740/) (`pubmed-observation-pmid-38540740-2026-04-16-641e5140165d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-38540740-ll-37-v1 SHA-256: 294da1e198322cf9ac6f5d15542ecfe5273733879b1f77c0fd33b26f0e4fc5c0.

---

<a id="pubmed-pmid-38604693-ll-37-v1"></a>

## \[Progress of researches on the antiparasitic activity of antimicrobial peptide LL-37\].

> PubMed lists PMID 38604693 in Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control as Review, English Abstract, Journal Article, with publication-date metadata of 2024-03-25 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38604693-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-04-30
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38604693-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-38604693-ll-37-v1
- Content SHA-256: `bd5b0fe544eedcab1c32c56b5ce7c7bd5fa36dd853eeeb13fa9817526d3933ee`

### Claims and source pins

#### Headline

\[Progress of researches on the antiparasitic activity of antimicrobial peptide LL-37\]. ([`pubmed-observation-pmid-38604693-2024-04-30-12bfb0c43304`](#source-pubmed-observation-pmid-38604693-2024-04-30-12bfb0c43304))

#### Summary

PubMed lists PMID 38604693 in Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control as Review, English Abstract, Journal Article, with publication-date metadata of 2024-03-25 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38604693-2024-04-30-12bfb0c43304`](#source-pubmed-observation-pmid-38604693-2024-04-30-12bfb0c43304))

#### Paragraph 1

PubMed lists PMID 38604693 in Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control as Review, English Abstract, Journal Article, with publication-date metadata of 2024-03-25 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38604693-2024-04-30-12bfb0c43304`](#source-pubmed-observation-pmid-38604693-2024-04-30-12bfb0c43304))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38604693-2024-04-30-12bfb0c43304`](#source-pubmed-observation-pmid-38604693-2024-04-30-12bfb0c43304))

### Sources

<a id="source-pubmed-observation-pmid-38604693-2024-04-30-12bfb0c43304"></a>
- **\[Progress of researches on the antiparasitic activity of antimicrobial peptide LL-37\]. · retained source version 1:2024-04-30:current:12bfb0c433040599028107bbd6ff7f5ac05645ecde6d03ef52f818592da200e2** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38604693/) (`pubmed-observation-pmid-38604693-2024-04-30-12bfb0c43304`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[Progress of researches on the antiparasitic activity of antimicrobial peptide LL-37\]." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-38604693-ll-37-v1 SHA-256: bd5b0fe544eedcab1c32c56b5ce7c7bd5fa36dd853eeeb13fa9817526d3933ee.

---

<a id="pubmed-pmid-39615616-ll-37-v1"></a>

## Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease.

> PubMed lists PMID 39615616 in Pharmacological research as Journal Article, Review, with publication-date metadata of 2024-11-28 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39615616-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-01-17
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39615616-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-39615616-ll-37-v1
- Content SHA-256: `a00bbdd6baa76a8b362b2cbd2a8b8dd53355fd0fb0c2cafb95561373431e23bc`

### Claims and source pins

#### Headline

Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease. ([`pubmed-observation-pmid-39615616-2025-01-17-c9b4084c72d2`](#source-pubmed-observation-pmid-39615616-2025-01-17-c9b4084c72d2))

#### Summary

PubMed lists PMID 39615616 in Pharmacological research as Journal Article, Review, with publication-date metadata of 2024-11-28 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39615616-2025-01-17-c9b4084c72d2`](#source-pubmed-observation-pmid-39615616-2025-01-17-c9b4084c72d2))

#### Paragraph 1

PubMed lists PMID 39615616 in Pharmacological research as Journal Article, Review, with publication-date metadata of 2024-11-28 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39615616-2025-01-17-c9b4084c72d2`](#source-pubmed-observation-pmid-39615616-2025-01-17-c9b4084c72d2))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39615616-2025-01-17-c9b4084c72d2`](#source-pubmed-observation-pmid-39615616-2025-01-17-c9b4084c72d2))

### Sources

<a id="source-pubmed-observation-pmid-39615616-2025-01-17-c9b4084c72d2"></a>
- **Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease. · retained source version 1:2025-01-17:current:c9b4084c72d2176c8d8bddd4a4e3d51e3b5004a1e772c341f8df1145a36641b7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39615616/) (`pubmed-observation-pmid-39615616-2025-01-17-c9b4084c72d2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-39615616-ll-37-v1 SHA-256: a00bbdd6baa76a8b362b2cbd2a8b8dd53355fd0fb0c2cafb95561373431e23bc.

---

<a id="pubmed-pmid-39643165-ll-37-v1"></a>

## LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity.

> PubMed lists PMID 39643165 in International journal of antimicrobial agents as Journal Article, Review, with publication-date metadata of 2024-12-04 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39643165-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-01-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39643165-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-39643165-ll-37-v1
- Content SHA-256: `932d2512b15775c7cda64d038da64f402f2e8861baffe590db73c102a36a0bae`

### Claims and source pins

#### Headline

LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity. ([`pubmed-observation-pmid-39643165-2025-01-07-f628957ee0d1`](#source-pubmed-observation-pmid-39643165-2025-01-07-f628957ee0d1))

#### Summary

PubMed lists PMID 39643165 in International journal of antimicrobial agents as Journal Article, Review, with publication-date metadata of 2024-12-04 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39643165-2025-01-07-f628957ee0d1`](#source-pubmed-observation-pmid-39643165-2025-01-07-f628957ee0d1))

#### Paragraph 1

PubMed lists PMID 39643165 in International journal of antimicrobial agents as Journal Article, Review, with publication-date metadata of 2024-12-04 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39643165-2025-01-07-f628957ee0d1`](#source-pubmed-observation-pmid-39643165-2025-01-07-f628957ee0d1))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39643165-2025-01-07-f628957ee0d1`](#source-pubmed-observation-pmid-39643165-2025-01-07-f628957ee0d1))

### Sources

<a id="source-pubmed-observation-pmid-39643165-2025-01-07-f628957ee0d1"></a>
- **LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity. · retained source version 1:2025-01-07:current:f628957ee0d106997d53076ac110455c94e27dc6b57ceb1e6d2ae27bce2f78cc** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39643165/) (`pubmed-observation-pmid-39643165-2025-01-07-f628957ee0d1`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-39643165-ll-37-v1 SHA-256: 932d2512b15775c7cda64d038da64f402f2e8861baffe590db73c102a36a0bae.

---

<a id="pubmed-pmid-39954662-ll-37-v1"></a>

## Cathelicidin LL-37 in periodontitis: current research advances and future prospects - A review.

> PubMed lists PMID 39954662 in International immunopharmacology as Journal Article, Review, with publication-date metadata of 2025-02-15 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39954662-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-05-07
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39954662-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-39954662-ll-37-v1
- Content SHA-256: `a12e489b6e3558b41ac27a0426db79f0c12528bdfa7f11a972d1dbbe3c2bc336`

### Claims and source pins

#### Headline

Cathelicidin LL-37 in periodontitis: current research advances and future prospects - A review. ([`pubmed-observation-pmid-39954662-2025-05-07-0259b10fccc2`](#source-pubmed-observation-pmid-39954662-2025-05-07-0259b10fccc2))

#### Summary

PubMed lists PMID 39954662 in International immunopharmacology as Journal Article, Review, with publication-date metadata of 2025-02-15 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39954662-2025-05-07-0259b10fccc2`](#source-pubmed-observation-pmid-39954662-2025-05-07-0259b10fccc2))

#### Paragraph 1

PubMed lists PMID 39954662 in International immunopharmacology as Journal Article, Review, with publication-date metadata of 2025-02-15 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39954662-2025-05-07-0259b10fccc2`](#source-pubmed-observation-pmid-39954662-2025-05-07-0259b10fccc2))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39954662-2025-05-07-0259b10fccc2`](#source-pubmed-observation-pmid-39954662-2025-05-07-0259b10fccc2))

### Sources

<a id="source-pubmed-observation-pmid-39954662-2025-05-07-0259b10fccc2"></a>
- **Cathelicidin LL-37 in periodontitis: current research advances and future prospects - A review. · retained source version 1:2025-05-07:current:0259b10fccc2a74878c65713d80a4f7db3c988e3d9072739bd7ac3f50f62c55c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39954662/) (`pubmed-observation-pmid-39954662-2025-05-07-0259b10fccc2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Cathelicidin LL-37 in periodontitis: current research advances and future prospects - A review." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-39954662-ll-37-v1 SHA-256: a12e489b6e3558b41ac27a0426db79f0c12528bdfa7f11a972d1dbbe3c2bc336.

---

<a id="pubmed-pmid-40869425-ll-37-v1"></a>

## Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications.

> PubMed lists PMID 40869425 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2025-08-21 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40869425-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-08-31
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40869425-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-40869425-ll-37-v1
- Content SHA-256: `01fbf2104caf5dbab2701678bb721d091cbbbb128074a38674c63a8cfb9dc37d`

### Claims and source pins

#### Headline

Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications. ([`pubmed-observation-pmid-40869425-2025-08-31-d205fb9bcc89`](#source-pubmed-observation-pmid-40869425-2025-08-31-d205fb9bcc89))

#### Summary

PubMed lists PMID 40869425 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2025-08-21 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40869425-2025-08-31-d205fb9bcc89`](#source-pubmed-observation-pmid-40869425-2025-08-31-d205fb9bcc89))

#### Paragraph 1

PubMed lists PMID 40869425 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2025-08-21 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40869425-2025-08-31-d205fb9bcc89`](#source-pubmed-observation-pmid-40869425-2025-08-31-d205fb9bcc89))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40869425-2025-08-31-d205fb9bcc89`](#source-pubmed-observation-pmid-40869425-2025-08-31-d205fb9bcc89))

### Sources

<a id="source-pubmed-observation-pmid-40869425-2025-08-31-d205fb9bcc89"></a>
- **Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications. · retained source version 1:2025-08-31:current:d205fb9bcc89f85d72f3d06628d865de520834ce55da061800626829984aa3ce** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40869425/) (`pubmed-observation-pmid-40869425-2025-08-31-d205fb9bcc89`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-40869425-ll-37-v1 SHA-256: 01fbf2104caf5dbab2701678bb721d091cbbbb128074a38674c63a8cfb9dc37d.

---

<a id="pubmed-pmid-40960088-ll-37-v1"></a>

## Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis.

> PubMed lists PMID 40960088 in Archivum immunologiae et therapiae experimentalis as Journal Article, Review, with publication-date metadata of 2025-09-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40960088-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-09-17
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40960088-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-40960088-ll-37-v1
- Content SHA-256: `26694e649226511020a9b38b2477e8d07525d29ee096d4866a27df831b94ebdf`

### Claims and source pins

#### Headline

Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis. ([`pubmed-observation-pmid-40960088-2025-09-17-49d37fef12d9`](#source-pubmed-observation-pmid-40960088-2025-09-17-49d37fef12d9))

#### Summary

PubMed lists PMID 40960088 in Archivum immunologiae et therapiae experimentalis as Journal Article, Review, with publication-date metadata of 2025-09-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40960088-2025-09-17-49d37fef12d9`](#source-pubmed-observation-pmid-40960088-2025-09-17-49d37fef12d9))

#### Paragraph 1

PubMed lists PMID 40960088 in Archivum immunologiae et therapiae experimentalis as Journal Article, Review, with publication-date metadata of 2025-09-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40960088-2025-09-17-49d37fef12d9`](#source-pubmed-observation-pmid-40960088-2025-09-17-49d37fef12d9))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40960088-2025-09-17-49d37fef12d9`](#source-pubmed-observation-pmid-40960088-2025-09-17-49d37fef12d9))

### Sources

<a id="source-pubmed-observation-pmid-40960088-2025-09-17-49d37fef12d9"></a>
- **Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis. · retained source version 1:2025-09-17:current:49d37fef12d96160c5ceeb37578b29e37a3db1428507107f23c0681358e73ef7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40960088/) (`pubmed-observation-pmid-40960088-2025-09-17-49d37fef12d9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-40960088-ll-37-v1 SHA-256: 26694e649226511020a9b38b2477e8d07525d29ee096d4866a27df831b94ebdf.

---

<a id="pubmed-pmid-41270816-ll-37-v1"></a>

## Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats.

> PubMed lists PMID 41270816 in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases as Journal Article, Review, with publication-date metadata of 2025-11-19 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41270816-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-12-15
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41270816-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-41270816-ll-37-v1
- Content SHA-256: `0faa486e9387392350a41398e5d865521ee39ed3fe4aa2b44f5e139253dce2cd`

### Claims and source pins

#### Headline

Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats. ([`pubmed-observation-pmid-41270816-2025-12-15-81ffc7562f62`](#source-pubmed-observation-pmid-41270816-2025-12-15-81ffc7562f62))

#### Summary

PubMed lists PMID 41270816 in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases as Journal Article, Review, with publication-date metadata of 2025-11-19 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41270816-2025-12-15-81ffc7562f62`](#source-pubmed-observation-pmid-41270816-2025-12-15-81ffc7562f62))

#### Paragraph 1

PubMed lists PMID 41270816 in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases as Journal Article, Review, with publication-date metadata of 2025-11-19 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41270816-2025-12-15-81ffc7562f62`](#source-pubmed-observation-pmid-41270816-2025-12-15-81ffc7562f62))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41270816-2025-12-15-81ffc7562f62`](#source-pubmed-observation-pmid-41270816-2025-12-15-81ffc7562f62))

### Sources

<a id="source-pubmed-observation-pmid-41270816-2025-12-15-81ffc7562f62"></a>
- **Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats. · retained source version 1:2025-12-15:current:81ffc7562f62edd1d151ae454bf5b1f421128e926d0350c4aa5d6e4ee7e0c3d9** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41270816/) (`pubmed-observation-pmid-41270816-2025-12-15-81ffc7562f62`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-41270816-ll-37-v1 SHA-256: 0faa486e9387392350a41398e5d865521ee39ed3fe4aa2b44f5e139253dce2cd.

---

<a id="pubmed-pmid-42095322-ll-37-v1"></a>

## LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease.

> PubMed lists PMID 42095322 in Immunity, inflammation and disease as Journal Article, Review, with publication-date metadata of 2026-05 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42095322-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-09-21
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42095322-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-42095322-ll-37-v1
- Content SHA-256: `08ae3e47f48e5b1a1ba96aee2a03843e82c53690d708b970153e1d6126bead40`

### Claims and source pins

#### Headline

LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease. ([`pubmed-observation-pmid-42095322-2026-09-21-e5cd8a2a860b`](#source-pubmed-observation-pmid-42095322-2026-09-21-e5cd8a2a860b))

#### Summary

PubMed lists PMID 42095322 in Immunity, inflammation and disease as Journal Article, Review, with publication-date metadata of 2026-05 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42095322-2026-09-21-e5cd8a2a860b`](#source-pubmed-observation-pmid-42095322-2026-09-21-e5cd8a2a860b))

#### Paragraph 1

PubMed lists PMID 42095322 in Immunity, inflammation and disease as Journal Article, Review, with publication-date metadata of 2026-05 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42095322-2026-09-21-e5cd8a2a860b`](#source-pubmed-observation-pmid-42095322-2026-09-21-e5cd8a2a860b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42095322-2026-09-21-e5cd8a2a860b`](#source-pubmed-observation-pmid-42095322-2026-09-21-e5cd8a2a860b))

### Sources

<a id="source-pubmed-observation-pmid-42095322-2026-09-21-e5cd8a2a860b"></a>
- **LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease. · retained source version 1:2026-09-21:current:e5cd8a2a860bb78fa8ee55889617890d9a1c5edebe375d1d8ec5a18f3240d3e7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42095322/) (`pubmed-observation-pmid-42095322-2026-09-21-e5cd8a2a860b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-42095322-ll-37-v1 SHA-256: 08ae3e47f48e5b1a1ba96aee2a03843e82c53690d708b970153e1d6126bead40.

---

<a id="pubmed-pmid-42861262-ll-37-v1"></a>

## LL-37-MRGPRX2-Mast Cell Signaling in Rosacea: Current Evidence and Directions for Human Studies.

> PubMed lists PMID 42861262 in Clinical, cosmetic and investigational dermatology as Journal Article, Review, with publication-date metadata of 2026-10-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42861262-ll-37:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-13
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42861262-ll-37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-42861262-ll-37-v1
- Content SHA-256: `899be6a48275f611b22c3c3a527e75120460d64d38020c5ab8b925ff6029bcc0`

### Claims and source pins

#### Headline

LL-37-MRGPRX2-Mast Cell Signaling in Rosacea: Current Evidence and Directions for Human Studies. ([`pubmed-observation-pmid-42861262-2026-10-13-14dadcde95e2`](#source-pubmed-observation-pmid-42861262-2026-10-13-14dadcde95e2))

#### Summary

PubMed lists PMID 42861262 in Clinical, cosmetic and investigational dermatology as Journal Article, Review, with publication-date metadata of 2026-10-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42861262-2026-10-13-14dadcde95e2`](#source-pubmed-observation-pmid-42861262-2026-10-13-14dadcde95e2))

#### Paragraph 1

PubMed lists PMID 42861262 in Clinical, cosmetic and investigational dermatology as Journal Article, Review, with publication-date metadata of 2026-10-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42861262-2026-10-13-14dadcde95e2`](#source-pubmed-observation-pmid-42861262-2026-10-13-14dadcde95e2))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42861262-2026-10-13-14dadcde95e2`](#source-pubmed-observation-pmid-42861262-2026-10-13-14dadcde95e2))

### Sources

<a id="source-pubmed-observation-pmid-42861262-2026-10-13-14dadcde95e2"></a>
- **LL-37-MRGPRX2-Mast Cell Signaling in Rosacea: Current Evidence and Directions for Human Studies. · retained source version 1:2026-10-13:current:14dadcde95e28d1ac56f292c880d87189d641acf965a06ee12a3a8171e29f789** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42861262/) (`pubmed-observation-pmid-42861262-2026-10-13-14dadcde95e2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "LL-37-MRGPRX2-Mast Cell Signaling in Rosacea: Current Evidence and Directions for Human Studies." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/ll-37.json#pubmed-pmid-42861262-ll-37-v1 SHA-256: 899be6a48275f611b22c3c3a527e75120460d64d38020c5ab8b925ff6029bcc0.

